Oncology Clinical Trials in Hartford, CT

As of July 2026, 50 paid clinical trials are recruiting for Oncology in Hartford, Connecticut. Oncology trials evaluate immunotherapies, targeted therapies, antibody-drug conjugates, and combination regimens across solid tumors and blood cancers — from early-phase first-in-human studies to phase 3 registration trials. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 17, 2026.

Filter results

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

50 clinical trials for Oncology

·Clear filters·↓ Download CSV

Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease

for Endometrial Cancer

Sites in Hartford +11 more locations

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: Female·Age: 18+

Code: NCT04291612·Recruiting·Listed Mar 2020

Apply to this trial

Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation

for Prostate Adenocarcinoma

Sites in Hartford, Glastonbury +130 more locations

Sponsor: SWOG Cancer Research Network

Sex: Male·Age: 18+

Code: NCT05806515·Phase 2·Recruiting·Listed Apr 2023

Apply to this trial

Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease

for Triple Negative Breast Cancer

Sites in Hartford, Norwalk +10 more locations

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 18+

Code: NCT03808337·Phase 2·Recruiting·Listed Jan 2019

Apply to this trial

Pembrolizumab, Olaparib, and Temozolomide for People With Glioma

for Glioma

Sites in Hartford +9 more locations

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 18+

Code: NCT05188508·Phase 2·Recruiting·Listed Jan 2022

Apply to this trial

Beat Childhood Cancer Specimen Banking and Data Registry

for Pediatric Cancer

Sites in Hartford +16 more locations

Sponsor: Giselle Sholler

Sex: All·Age: All ages·Accepts healthy volunteers

Code: NCT04715178·Recruiting·Listed Jan 2021

Apply to this trial

Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma

for Neuroblastoma

Sites in Hartford +5 more locations

Sponsor: Dana-Farber Cancer Institute

Sex: All·Age: Up to 17

Code: NCT06831552·Recruiting·Listed Feb 2025

Apply to this trial

Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia

for Acute Leukemia

Sites in Hartford +1 more location

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 18 - 80

Code: NCT02677064·Recruiting·Listed Feb 2016

Apply to this trial

A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer

for Cervical Cancer

Sites in Hartford, New Britain +124 more locations

Sponsor: GOG Foundation

Sex: Female·Age: 18+

Code: NCT04831580·Recruiting·Listed Apr 2021

Apply to this trial

Improving Communication Between AYA Oncology Patients and Clinicians: A Patient-Centered Intervention

for Pediatric Cancer

1 location in Hartford

Sponsor: Connecticut Children's Medical Center

Sex: All·Age: 15 - 25

Code: NCT06982066·Recruiting·Listed May 2025

Apply to this trial

A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)

for Biliary Tract Cancer

Drug: Rilvegostomig

Sites in Hartford, New Haven +33 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT07221253·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

Conditions in Oncology (Hartford, CT)

Non-small cell lung cancer (NSCLC)· 8 Neuroblastoma· 8 Breast cancer· 6 Solid tumor· 6 Leukemia (other)· 5 Prostate cancer· 3 Ovarian cancer· 3 Myelodysplastic syndromes (MDS)· 3 Osteosarcoma· 3 Metastatic breast cancer· 2 Lung cancer· 2 Pancreatic cancer· 2 Biliary tract cancer· 2 Endometrial cancer· 2 Acute myeloid leukemia (AML)· 2 Myeloproliferative neoplasm· 2 Non-Hodgkin lymphoma· 2 Mantle cell lymphoma· 2 Ewing sarcoma· 2 Pediatric cancer· 2 Cancer (any)· 2 Triple-negative breast cancer· 1 HER2-positive breast cancer· 1 Esophageal cancer· 1 Gastrointestinal cancer· 1 Bladder cancer· 1 Cervical cancer· 1 Gynecologic cancer· 1 Glioblastoma· 1 Glioma· 1 Multiple myeloma· 1 Acute lymphoblastic leukemia· 1 Myelofibrosis· 1 Follicular lymphoma· 1 Marginal zone lymphoma· 1 Hematologic malignancy· 1 Melanoma· 1 Head and neck cancer· 1 Rhabdomyosarcoma· 1 Mesothelioma· 1 Neuroendocrine tumors· 1